Rose Hips: the Fruit of the Rose
Upon first site, people commonly mistake rose hips for a type of berry. They are not berries of course, but an accessory fruit to the rose plant. For the botany nerds out there, an accessory fruit is a fruit in which some of the flesh is derived not from the floral ovary but from some adjacent tissue exterior to the carpel.
There are many, many types of rose plants out there, but for Alaskans, ours is the Arctic Rose, aka Rosa Acicularis in the north, Nootka Rose, or Rosa Nutkana in the south and along the coast, and then finally the Sitka Rose.
Products that we make containing rose hips:
Tundra Day CBD Tea: https://www.tundratonics.com/tundra-tonics-store/p/tundra-day-cbd-tea-guayusa-yaupon-rose-hips-schisandra-berry-and-more
Wild Alaskan Rosehip and Stinkweed Syrup: https://www.tundratonics.com/tundra-tonics-store/p/wild-alaskan-rose-hip-syrup-organic-herbal-blend-with-alaskan-wormwood-aka-stinkweed-local-fireweed-honey-and-rose-hips
Tundra Tea Herbal Blend: https://www.tundratonics.com/tundra-tonics-store/p/organ-alaskan-herbal-tea-blend-wild-alaskan-wormwood-blue-butterfly-calming-herbal-blend
Rose Hip Double-Extract: https://www.tundratonics.com/tundra-tonics-store/p/rosehip-tincture-wild-alaska-rosehips-rosa-aciclaris-prickly-rose
Famous for their bright pink edible flowers, and also famous for their beautiful white crab spider companions that live in these bushes (pretty prolifically I might add). Sidenote, crab spiders are described as docile, but almost everyone I’ve ever come across has raised its front legs in the defensive posture of being battle-ready.
Rose hips are commonly made into jams, jellies, syrups, dried for tea, soup, wine, and other preparations. They have been frozen, eaten fresh, chewed, mixed with dried salmon eggs, some people claim to make tea from the leaves.
They have definitively been used since pre-historic times. It’s pretty safe to say that we humans have established a good relationship to this easy-going forage-able.
Rose hips are even an ingredient used in the popular women’s libido supplement, Lady Prelox: https://www.ladyprelox.com/clinical-studies/studies-into-lady-prelox/
Bioactive Compounds Found in Rose Hips:
The carotenoids beta-carotene, lutein, zeaxanthin and lycopene. (also found in tomatoes, carrots)
Vitamin C
Vitamin A
Oleic Acid
Palmitic Acid
Linoleic Acid
Gamma Linolenic Acid
Quercetin
Rutin
Catachins
“Vitamin F” (ALA and LA)
Tocopherols
Anthocyanin
This is not a comprehensive list of literally everything found in the various species of rose hips, but merely a lineup of the “heavy-hitters”, or the “rock-star” compounds that are the chief subjects of interest.
I’ll confess, that I ignored rose hips for way too long in my excitement for mushrooms and more exotic plants. People would always try to sell me on rose hips due to their vitamin c content, yet this isn’t even their most prominent benefit at all. For native peoples who lived here prior to supermarkets and the internet, then YES, rose hips would be a highly valuable source of nutrition. Vitamin C for modern people though, is relatively abundant.
These days, I’m CONSTANTLY adding them to my teas, I sip on our rose hip syrup, and I take our rose hip tincture (typically when I’m in the car and therefore not occupied doing a dozen or so other things).
Continue on below to introduce yourself to some of the more compelling rose hip research out there.
Research:
https://www.sciencedirect.com/science/article/abs/pii/S0944711319301278
Rosa canina – Rose hip pharmacological ingredients and molecular mechanics counteracting osteoarthritis – A systematic review
Results
In particular, 24 pharmacological studies on Rosa canina or preparations thereof were considered relevant. Potent antioxidant radical scavenging effects are well documented for numerous rose hip constituents besides Vitamin C. Furthermore, anti-inflammatory activities include the reduction of pro-inflammatory cytokines and chemokines, reduction of NF-kB signaling, inhibition of pro-inflammatory enzymes, including COX1/2, 5-LOX and iNOS, reduction of C-reactive protein levels, reduction of chemotaxis and chemoluminescence of PMNs, and an inhibition of pro-inflammatory metalloproteases.
Conclusion
The antioxidant and anti-inflammatory effects of Rosa canina match its clinical action – especially considering new findings on the pharmacological disease pattern of OA. The entirety of several compounds including phenolics, terpenoids, galactolipids, carotenoids, fruit acids and fatty oils can be considered responsible for the observed pharmacological and clinical effects. Further research is needed to eludicate how and in which manner single rose hip compounds interact with their molecular pharmacological targets.
Ketoprofen-loaded rose hip oil nanocapsules attenuate chronic inflammatory response in a pre-clinical trial in mice
This study aimed to develop nanocapsules containing ketoprofen using rose hip oil (Keto-NC) as oil core, and to evaluate their anti-inflammatory activity in acute and chronic ear edema models in mice. Physicochemical characterization, drug release, photostability and cytotoxicity assays were performed for the developed Keto-NC formulations and compared to ketoprofen-loaded nanocapsules using medium chain triglycerides as oil core (Keto-MCT-NC). Anti-inflammatory activity of orally delivered KP (Ketoprofen-free; 10 mg.kg−1) or Keto-NC (2.5; 5; 10 mg.kg−1) was assessed in mouse acute and chronic ear edema induced by croton oil (CO). Edema histological characteristics were determined by H&E stain, and redox parameters were analyzed in blood plasma and erythrocytes. Keto-MCT-NC and Keto-NC did not exhibit differences regarding physicochemical parameters, including size diameters, polydispersity index, pH, Ketoprofen content, and encapsulation efficiency. However, Keto-NC, which contains rose hip oil as lipid core, decreased drug photodegradation under UVC radiation when compared to Keto-MCT-NC. KP or Keto-NC were not cytotoxic to keratinocyte cultures and produced equal edema inhibition in the acute protocol. Conversely, in the chronic protocol, Keto-NC was more effective in reducing edema (~60–70% on 7-9th days of treatment) when compared to KP (~40% on 8–9th days of treatment). This result was confirmed by histological analysis, which indicated reduction of edema and inflammatory infiltrate. A sub-therapeutic dose of Keto-NC (5 mg.kg−1) significantly reduced edema when compared to control. Finally, KP and Keto-NC exhibited similar effects on redox parameters, suggesting that the advantages associated with Ketoprofen nanoencapsulation did not involve oxidative stress pathways. The results showed that Keto-NC was more efficient than KP in reducing chronic inflammation. These data may be important for the development of strategies aiming treatment of chronic inflammatory diseases with fewer adverse effects.
https://www.sciencedirect.com/science/article/pii/S0928493118315339
Rose hip as an underutilized functional food: Evidence-based review
The search for nutrient-dense food source is a top-priority in today's food-challenged world of multi-billion population. Food insecurity has become especially critical in developing countries, though potential sources of functional foods are being wasted right before our eyes. Rose hips, the fruits of rose plants (Rosa sp.) have been discovered to be rich in polyphenols (triterpene acids, flavonoids, proanthocyanidins, catechin), essential fatty acids, galactolipid, folate, vitamin A, C and E, minerals (Ca, Mg, K, S, Si, Se, Mn and Fe), among other bioactive components. The extracts have been proven to possess antioxidant, anti-inflammatory, immunomodulation, anticancer, cardioprotective, antidiabetic, neuroprotective, and antimicrobial properties. The extracts have been validated beneficial against non-alcoholic fatty liver disease, osteoarthritis, rheumatoid arthritis, obesity, cancer, kidney stone, depression, dermal issues, among other pathologies. The mechanisms of therapeutic actions involve intervention in COX-2, iNOS, NF-kappaB, PPAR-γ, p38 MAPK, Bak, Caspase-3, Ca++ channel blockade pathways. Barring the Rosaceae family-characteristic allergenicity due to LTPs, the rose hips are free of other side effects. This holistic review, based on recent findings is excited to report rose hips as an emerging ‘functional food’ that deserves to be integrated to food platter without delay.
https://www.sciencedirect.com/science/article/abs/pii/S0924224416304277
Rosehip - an evidence based herbal medicine for inflammation and arthritis
Background: Rosehips - which contain a particular type of galactolipid - have a specific antiinflammatory action. A standardised rosehip powder has been developed to maximise the retention of phytochemicals. This powder has demonstrated antioxidant and anti-inflammatory activity as well as clinical benefits in conditions such as osteoarthritis, rheumatoid arthritis and inflammatory bowel disease.
Objective: To examine the evidence suggesting that standardised rosehip powder may be a viable replacement or supplement for conventional therapies used in inflammatory diseases such as arthritis.
Discussion: A meta-analysis of three randomised controlled trials involving 287 patients with a median treatment period of 3 months reported that treatment with standardised rosehip powder consistently reduced pain scores and that patients allocated to rosehip powder were twice as likely to respond to rosehip compared to placebo. In contrast to nonsteroidal anti-inflammatory drugs and aspirin, rosehip has antiinflammatory actions that do not have ulcerogenic effects and do not inhibit platelets nor influence the coagulation cascade or fibrinolysis.
https://pubmed.ncbi.nlm.nih.gov/22762068/
Rose hip supplementation increases energy expenditure and induces browning of white adipose tissue
Background: Overweight and obesity are widespread chronic disorders defined as excessive fat accumulation, and are major risk factors for several chronic diseases including type 2 diabetes, coronary heart disease, high blood pressure and fatty liver. Changes in lifestyle such as increased physical activity and a healthy diet can be crucial tools for treating obesity. Intake of rose hip, the fruit of several plants belonging to the Rosaceae family, has been shown to reduce body fat mass and prevent body weight gain. Thus, the aim of the study was to elucidate potential mechanisms through which rose hip inhibit diet-induced obesity.
Methods: C57BL/6 J mice were fed a high fat diet with (RH) or without (CTR) rose hip supplementation for three months. In vivo indirect calorimetry was monitored, as well as gene expression and protein levels of different adipose depots.
Results: Although no differences in energy intake were found compared to the CTR group, RH prevented body weight gain and lowered blood glucose, insulin and cholesterol levels. Indirect calorimetry showed that RH-fed mice have significantly higher EE during the dark phase, despite comparable voluntary activity. Moreover, when challenged with treadmill running, RH-fed mice exhibited higher metabolic rate. Therefore, we hypothesized that RH could stimulate the brown adipose tissue (BAT) thermogenic capacity or may induce browning of the white adipose tissue (WAT). Compared to the CTR group, gene expression and protein levels of some brown and "brite" markers, together with genes able to promote brown adipocyte differentiation and thermogenesis (such as ucp1, tbx15, bmp7, and cidea), as well as phosphorylation of AMPK, was increased in WAT (but not in BAT) of RH-fed mice.
Conclusions: Taken together these results indicate that dietary rose hip prevents body weight gain by increasing whole body EE and inducing browning of WAT. Thus, it has potential therapeutic implication for treatment of obesity and related metabolic disorders.
https://pubmed.ncbi.nlm.nih.gov/27980600/
Phytochemistry, Traditional Uses and Pharmacological Profile of Rose Hip: A Review
Background: The fruit of genus Rosa, known as "rose hip", is frequently used in different traditional medicines. Rose hips have long been used to treat kidney stones, gastroenteric ailments, hypertension and respiratory problems such as bronchitis, cough and cold.
Aim: This review is focused on the ethnopharmacological uses of rose hip as well as phytochemical and pharmacological aspects.
Results: Ethno-medical uses of rose hip have been recorded in many countries since a long time. Approximately, 129 chemical compounds have been isolated and identified from rose hip. This fruit contains some major active components such as flavonoids, tannins, anthocyanin, phenolic compounds, fatty oil, organic acids and inorganic compounds. Scientific studies have suggested a wide range of pharmacological activities for rose hip including antioxidant, anti-inflammatory, anti-obesity, anti-cancer, hepatoprotective, nephroprotective, cardioprotective, antiaging, anti H. pylori, neuroprotective and antinociceptive activities. In particular, the rose hip powder and extract have been reported to exert therapeutic effects on arthritis.
Conclusion: Some of the ethnomedical indications of rose hip, such as nephroprotective and gastroproetctive actions, have been confirmed by preclinical pharmacological studies. Additional investigations on the pharmacological effects of rose hip as well as evidence from randomized controlled trials are essential to assess the therapeutic value of this natural product.
Keywords: R. multiflora; Rosa canina; Rosaceae; anti-cancer; apigenin; catechin; cornuside; gallic acid; linoleic acid; liver and kidney protection; osteoarthritis; palmitic acid; protocatechuic acid; quercetin; rose hip; shikmic acid; β- naringenin hexoside..
https://pubmed.ncbi.nlm.nih.gov/30317989/
Effects of rose hip intake on risk markers of type 2 diabetes and cardiovascular disease: a randomized, double-blind, cross-over investigation in obese persons
Background/objectives: In studies performed in mice, rose hip powder has been shown to both prevent and reverse high-fat diet-induced obesity and glucose intolerance as well as reduce plasma levels of cholesterol. The aim of this study was to investigate whether daily intake of rose hip powder over 6 weeks exerts beneficial metabolic effects in obese individuals.
Subjects/methods: A total of 31 obese individuals with normal or impaired glucose tolerance were enrolled in a randomized, double-blind, cross-over study in which metabolic effects of daily intake of a rose hip powder drink over 6 weeks was compared with a control drink. Body weight, glucose tolerance, blood pressure, blood lipids and markers of inflammation were assessed in the subjects.
Results: In comparison with the control drink, 6 weeks of daily consumption of the rose hip drink resulted in a significant reduction of systolic blood pressure (-3.4%; P=0.021), total plasma cholesterol (-4.9%; P=0.0018), low-density lipoprotein (LDL) cholesterol (-6.0%; P=0.012) and LDL/HDL ratio (-6.5%; P=0.041). The Reynolds risk assessment score for cardiovascular disease was decreased in the rose hip group compared with the control group (-17%; P=0.007). Body weight, diastolic blood pressure, glucose tolerance, and plasma levels of high-density lipoprotein (HDL) cholesterol, triglycerides, incretins and markers of inflammation did not differ between the two groups.
Conclusions: Daily consumption of 40 g of rose hip powder for 6 weeks can significantly reduce cardiovascular risk in obese people through lowering of systolic blood pressure and plasma cholesterol levels.
https://pubmed.ncbi.nlm.nih.gov/22166897/
The anti-inflammatory properties of rose-hip
The anti-inflammatory properties of rose-hip are described in this short report. Rose-hip extract reduced chemotaxis of peripheral blood neutrophils and monocytes of healthy subjects in vitro. Daily intake of rose-hip powder for four weeks by healthy volunteers and patients suffering from osteoarthritis, resulted in reduced serum C-reactive protein (CRP) levels and reduced chemotaxis of peripheral blood neutrophils. The results indicate that rose-hip possesses anti-inflammatory properties and might be used as a replacement or supplement for conventional drug therapies in patients with osteoarthritis.
https://pubmed.ncbi.nlm.nih.gov/17657447/
[The clinical effectiveness of rosehip powder in patients with osteoarthritis. A systematic review]
Aim: The objective of this systematic review was to present and evaluate the current evidence for the clinical effectiveness of treatment with rosehip powder in patients with osteoarthritis.
Method: A systematic search of the literature (Medline, EMBASE, Cochrane Collaboration Library) of all publications up to February 2006 was conducted. The terms searched for were rose hip, rosehip, Rosa canina, Hagebutte and osteoarthritis, arthritis and arthrosis. The studies turned up were subjected to a standardized assessment of method and content.
Results: Two double-blind randomized studies were analysed: both were relatively small (N = 100 and 112) and had a Jadad score of 5. In both studies, the rosehip powder LitoZin was employed. In the first study (parallel design; endpoint after 4 months), it was found that rosehip powder, in comparison with placebo, significantly improved hip flexion (p < 0.05), but no significant change was observed for internal and external rotation of the hips or in flexion of the knee. In the second study (crossover design, endpoints after 3 and 6 months) 66% of the patients receiving the test substance, and 35% of the patients on placebo reported a reduction in pain after3 months (p < 0.0128). A comparison of the consumption of analgesics after 3 months revealed no significant difference between the two groups. A comparison after 6 months showed no difference in the two endpoints, which, however, might be due to a possible carryover effect.
Conclusion: In both studies rosehip powder had a moderate effect in patients with osteoarthritis.
https://pubmed.ncbi.nlm.nih.gov/17619600/
Does the hip powder of Rosa canina (rosehip) reduce pain in osteoarthritis patients?--a meta-analysis of randomized controlled trials
Objective: Meta-analysis of randomized controlled trials (RCTs)--of a hip powder of Rosa canina (rosehip) preparation for symptomatic treatment of osteoarthritis (OA), in order to estimate the empirical efficacy as a pain reducing compound.
Method: RCTs from systematic searches were included if they explicitly stated that OA patients were randomized to either rosehip or placebo. The primary outcome was reduction in pain calculated as effect size (ES), defined as the standardized mean difference (SMD). As secondary analysis the number of responders to therapy was analyzed as Odds Ratios (OR), and expressed as the Number Needed to Treat (NNT). Restricted Maximum Likelihood (REML) methods were applied for the meta-analyses using mixed effects models.
Results: The three studies (287 patients and a median trial-duration of 3 months)--all supported by the manufacturer (Hyben-Vital International)--showed a reduction in pain scores by rosehip powder (145 patients) compared to placebo (142 patients): ES of 0.37 [95% confidence interval (CI): 0.13-0.60], P=0.002. Test for homogeneity seemed to support that the efficacy was consistent across trials (I(2)=0%). Thus it seems reasonable to assume that the three studies were measuring the same overall effect. It seemed twice as likely that a patient allocated to rosehip powder would respond to therapy, compared to placebo (OR=2.19; P=0.0009); corresponding to a NNT of six (95% CI: 4-13) patients.
Conclusions: Although based on a sparse amount of data, the results of the present meta-analysis indicate that rosehip powder does reduce pain; accordingly it may be of interest as a nutraceutical, although its efficacy and safety need evaluation and independent replication in a future large-scale/long-term trial.
https://pubmed.ncbi.nlm.nih.gov/18407528/
A powder made from seeds and shells of a rose-hip subspecies (Rosa canina) reduces symptoms of knee and hip osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial
Objective: The aim of this study was to determine whether a herbal remedy made from a subspecies of rose-hip (Rosa canina) might reduce symptoms of osteoarthritis and consumption of rescue medication in patients suffering from osteoarthritis.
Methods: Ninety-four patients with osteoarthritis of the hip or knee were enrolled in a randomized, placebo-controlled, double-blind crossover trial. Forty-seven patients were given 5 g of the herbal remedy daily for a period of 3 months and the remaining patients were given a similar amount of placebo. The group initially treated with placebo was then changed to rose-hip and vice versa for another 3-month period. Upon inclusion and after 3 weeks and 3 months of each treatment period, pain, stiffness, disability, and global severity of the disease were scored on a Western Ontario and McMaster Universities (WOMAC) questionnaire. After 3 weeks of treatment, patients, if possible, were allowed to reduce their consumption of 'rescue medication'. Data were analysed on the basis of intention to treat.
Results: Rose-hip resulted in a significant reduction in WOMAC pain (p<0.014) as compared to placebo, when testing after 3 weeks of treatment. The consumption of 'rescue medication' significantly declined as a result of active treatment (p<0.027). WOMAC disability, stiffness, and global assessment of severity of the disease were not altered by 3 weeks but decreased significantly (p<0.018, p<0.038, and p<0.035, respectively) after 3 months of treatment.
Conclusion: The data suggest that the present herbal remedy can alleviate symptoms of osteoarthritis and reduce the consumption of 'rescue medication'.
https://pubmed.ncbi.nlm.nih.gov/16195164/
Effect of Rosa canina L. (Rose-hip) on cold during winter season in a middle-class population: A randomized, double-blinded, placebo-controlled trial
Aim
The common cold has social and economic implications worldwide. This study aimed to test if a liquid standardised preparation, Hyben Vital, based on shells from Rose-hip (Rosa canina L.), reduces the incidence and symptoms of the common cold in Danish middle-class volunteers.
Methods
Volunteers (n = 120) were randomly allocated to daily treatments with either 2 g of liquid Rose-hip (RH) or placebo (P) for six months during winter. Primary effect variables: The frequency of colds and symptoms related to cold. Secondary effect variables: Evaluations from diaries of muscle stiffness and general well-being (numerical scales).
Results
A number of 107 volunteers completed the trial and 31 out of 58 patients (53.4%) in the P group reported cold vs 24 out of 55 patients (43.6%) in the RH group; 18.4% reduction (p = 0.348). The numbers of volunteers reporting the different symptoms of cold in P-group vs RH-group were: Coughing: 23 vs 18, p < 0.422; Headache: 26 vs 17, p < 0.112; Muscle stiffness: 27 vs 15, p < 0.027 and Fatigue: 29 vs 20, p < 0.115. Muscle stiffness, evaluated over 6 month, fell from initial 2.40 ± 2.32 to 2.02 ± 2.15 in the RH group and from 2.37 ± 2.40 to 2.93 ± 2.50 in the P group, (p < 0.043, comparing groups). The delta improvement in general well-being was 0.21 ± 0.74 (p < 0.019) vs 0.12 ± 1.08 (p < 0.078) in the RH-and P group, respectively (p < 0.861, comparing groups).
Conclusion
Our data suggest that administration of liquid Rose-hip reduces the incidence of colds by 18% and lowers the number of patients reporting the different symptoms of cold.
https://www.sciencedirect.com/science/article/abs/pii/S2210803318300265
Dietary rose hip exerts antiatherosclerotic effects and increases nitric oxide-mediated dilation in ApoE-null mice
Abstract
Atherosclerosis is a disease in which atheromatous plaques develop inside arteries, leading to reduced or obstructed blood flow that in turn may cause stroke and heart attack. Rose hip is the fruit of plants of the genus Rosa, belonging to the Rosaceae family, and it is rich in antioxidants with high amounts of ascorbic acid and phenolic compounds. Several studies have shown that fruits, seeds and roots of these plants exert antidiabetic, antiobesity and cholesterol-lowering effects in rodents as well as humans. The aim of this study was to elucidate the mechanisms by which rose hip lowers plasma cholesterol and to evaluate its effects on atherosclerotic plaque formation. ApoE-null mice were fed either an HFD (CTR) or HFD with rose hip supplementation (RH) for 24 weeks. At the end of the study, we found that blood pressure and atherosclerotic plaques, together with oxidized LDL, total cholesterol and fibrinogen levels were markedly reduced in the RH group. Fecal cholesterol content, liver expression of Ldlr and selected reverse cholesterol transport (RCT) genes such as Abca1, Abcg1 and Scarb1 were significantly increased upon RH feeding. In the aorta, the scavenger receptor Cd36 and the proinflammatory Il1β genes were markedly down-regulated compared to the CTR mice. Finally, we found that RH increased nitric oxide-mediated dilation of the caudal artery. Taken together, these results suggest that rose hip is a suitable dietary supplement for preventing atherosclerotic plaques formation by modulating systemic blood pressure and the expression of RCT and inflammatory genes.
https://www.sciencedirect.com/science/article/pii/S0955286316301887
A Novel Rose Hip Preparation with Enhanced Anti-Inflammatory and Chondroprotective Effects
Rose hip powder (RHP) alleviates osteoarthritis (OA) due to its anti-inflammatory and cartilage-protective properties. Substances contained in RHP might contribute to its clinical efficacy. The activity of two RHP (i.e., RH-A, from the whole fruit, RH-B, from fruits without seeds) was investigated in human peripheral blood leukocytes (PBL) and primary chondrocytes (NHAC-kn). RH-A and RH-B diminished the secretion of chemokines and cytokines in LPS/IFN-γ-activated PBL, including CCL5/RANTES, CXCL10/IP-10, interleukin- (IL-) 6, and IL-12. Most effects were transcriptional, since gene expression levels were significantly influenced by RH-A and RH-B. In IL-1β treated normal chondrocytes (NHAC-kn), both RH preparations reduced the expression of matrix metalloproteinase- (MMP-) 1, MMP-3, and MMP-13 and ADAMTS-4. These changes are associated with diminished inflammatory damage or cartilage erosion. Principal component analysis revealed that (1) RH-A and RH-B modified a large pattern of biomarkers, and (2) RH-B outperformed RH-A. Furthermore, RH-B contained more chondroprotective and anti-inflammatory constituents than RH-A. Thus, RHP contributed to restore cellular homeostasis in PBL and chondrocytes. RH preparations from fruits without seeds are thus expected to have an improved OA-preventive or OA-therapeutic profile, as subsequently shown in a related clinical trial.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211164/
Overall, there is TONS of research and history that documents the potency of rose hips in regards to our health and biology, hopefully this introductory write-up will serve you well in teaching you the basics and sending you out in the right directions to continue researching them.
Products that we make containing rose hips:
Tundra Day CBD Tea: https://www.tundratonics.com/tundra-tonics-store/p/tundra-day-cbd-tea-guayusa-yaupon-rose-hips-schisandra-berry-and-more
Wild Alaskan Rosehip and Stinkweed Syrup: https://www.tundratonics.com/tundra-tonics-store/p/wild-alaskan-rose-hip-syrup-organic-herbal-blend-with-alaskan-wormwood-aka-stinkweed-local-fireweed-honey-and-rose-hips
Tundra Tea Herbal Blend: https://www.tundratonics.com/tundra-tonics-store/p/organ-alaskan-herbal-tea-blend-wild-alaskan-wormwood-blue-butterfly-calming-herbal-blend
Rose Hip Double-Extract: https://www.tundratonics.com/tundra-tonics-store/p/rosehip-tincture-wild-alaska-rosehips-rosa-aciclaris-prickly-rose
